Phase I (Completed)
Phase I leveraged existing DoD, academic, and civilian partnerships and provided a solid foundation of excellence to build a unique electronically merged data pipeline (e-MERGE) and REDI-NET pathogen spillover alert dashboard, supported by Gold standard reach-back labs with field-ready hi-tech SOPs for standardized remote DNA-based pathogen detection. The REDI-NET alert dashboard, with built-in functionality and data quality assurance for downstream use in mathematical modeling, informed of changes with the relative portions on the contributory components of each pathogen with regard to baseline data, and generated prior warning of potential spillover events in real-time, initiating response and mitigating risks to global citizens and deployed warfighters.
A central function of the e-MERGE analysis pipeline developed to include novel risk maps and models.
Phase II (Currently active)
Phase II will expand the sampling frame of the established complementary diagnostic workflow developed under Phase I into new ecologies or terrain. Phase II will expand the REDI-NET pathogen portfolio to include opportunistic vDNA outputs and an enhanced data warehouse, develop an actionable workflow for early pathogen detection by remote forward-facing laboratories using the e-MERGE pipeline, and transfer knowledge of REDI-NET technology and processes to key DoD stakeholders.
Sampling expansion will serve to establish new mobile laboratories, for further reach of threat characterization, as well as, verify the correctness of Phase I threat forecast models through new/updated parameters to confirm emergence of targeted vectors and pathogens.
Phase III (proposed)
Phase III will focus on establishing new regional satellite laboratories (Bronze) to expand upon Phase I and Phase II outputs and integrate new remote data acquisition technologies to assess emerging disease threats. To support those new laboratories and the active vertebrate DNA (vDNA) surveillance, a new Gold Laboratory will be established at the University of Arkansas. Phase III will expand the REDI-NET pathogen portfolio to include active vDNA sampling and field metadata collection; establish, maintain, and expand REDI-NET active surveillance of iDNA and eDNA across varied ecologies and the Geographical Combatant Commands (GCCs) for broad spectrum pathogen detection using established SOPs; and readiness for roll-out of the REDI-NET platform to Senior DoD Officials in six GCCs and the AFHSC-GEIS partner network.
As data accrual improves, strategic sampling will become model-driven.
Phase IV (proposed in 2 separate fiscal years)
Phase IV will focus on rolling out the REDI-NET e-MERGE pipeline to Global Combatant Commands to assess emerging disease threats and ensure robust Force Health Protection and Force Readiness. Phase IV aims to install the REDI-NET into Joint Force pathogen surveillance activities in the Global Combatant Commands, harmonizing and synergizing the existing surveillance efforts, bolstered with Memorandum of Understandings (MOUs) and Material Transfer Agreements (MTAs). REDI-NET will provide administrative and technical support, and actively engage and train DoD stakeholders to ensure knowledge transfer of established protocols and database functionality. The Gold REDI-NET Laboratories will provide technical expertise and critical reach-back support to Joint Force stakeholders within the Combatant Commands as they drive to integrate the REDI-NET pipelines into existing emerging pathogen surveillance efforts to establish an empowered world-class pathogen detection and mitigation system to maintain U.S. Force Readiness and remotely predict the impact of emerging and emergent pathogesn on Force Health Protection in uncharted theatres.